Abstract: M-CSF/CSF-1 supports the proliferation and differentiation of monocytes and macrophages. In mice, CSF-1 also promotes proinflammatory responses in vivo by regulating mature macrophage functions, but little is known about the acute effects of this growth factor on mature human macrophages. Here, we show that in contrast to its effects on mouse bone marrow-derived macrophages, CSF-1 did not induce expression of urokinase plasminogen activator mRNA, repress expression of apolipoprotein E mRNA, or prime LPS-induced TNF and IL-6 secretion in human monocyte-derived macrophages (HMDM) from several independent donors. Instead, we show by expression profiling that CSF-1 modulates the HMDM transcriptome to favor a proatherogenic environment. CSF-1 induced expression of the proatherogenic chemokines CXCL10/IFN-inducible protein 10, CCL2, and CCL7 but repressed expression of the antiatherogenic chemokine receptor CXCR4. CSF-1 also up-regulated genes encoding enzymes of the cholesterol biosynthetic pathway (HMGCR, MVD, IDI1, FDPS, SQLE, CYP51A1, EBP, NSDHL, DHCR7, and DHCR24), and expression of ABCG1, encoding a cholesterol efflux transporter, was repressed. Consistent with these effects, CSF-1 increased levels of free cholesterol in HMDM, and the selective CSF-1R kinase inhibitor GW2580 ablated this response. These data demonstrate that CSF-1 represents a further link between inflammation and cardiovascular disease and suggest two distinct mechanisms by which CSF-1, which is known to be present in atherosclerotic lesions, may contribute to plaque progression. J. Leukoc. Biol. 85: 000 -000; 2009.
INTRODUCTION
M-CSF/CSF-1 acts on progenitor cells and mature cells of the mononuclear phagocyte system. The CSF-1R mediates all known effects of CSF-1, and its expression is normally restricted to the mononuclear phagocyte system and cells of the decidua and placental trophoblast [1] . CSF-1 stimulates proliferation of myeloid progenitors in the bone marrow and drives their differentiation into circulating monocytes and ultimately, tissue macrophages. It is the major, but not the only, factor that influences the growth and development of macrophages and related cells [2] . In the mouse, mononuclear phagocytes at different sites in the body show differential dependency on CSF-1; some populations rely particularly on circulating or local CSF-1 [3] , and others are CSF-1-independent [2] . Surprisingly, mice deficient in all three myeloid CSFs (CSF-1, G-CSF, and GM-CSF) possess myeloid progenitors, monocytes, macrophages, and neutrophils [4] , indicating that other factors can support myelopoiesis in the absence of CSFs. IL-34 was identified recently as an alternative, functional ligand for the CSF-1R [5] , so it is possible that this cytokine contributes to CSF-independent monocyte/macrophage development.
Macrophage populations differentiated under the influence of different CSFs have distinct phenotypes and functions. For example, mouse macrophages differentiated in the presence of GM-CSF exhibit a more proinflammatory phenotype than those differentiated in CSF-1 [6] . Differential effects of GM-CSF versus CSF-1 are also apparent during human monocyte-tomacrophage differentiation [7, 8] , with CSF-1-induced human macrophage differentiation favoring an M2-polarized phenotype, as assessed by transcriptional profiling [9] . This phenotype is likely to predominate under homeostatic conditions, as CSF-1 is constitutively present in vivo (2-30 ng/ml in normal human serum) [10, 11] . CSF-1 levels are elevated further in various pathological states [12] , and several lines of evidence suggest that this growth factor has additional functions in regulating mature macrophage function in such settings.
In mice, CSF-1 production increases in response to TNF, IFN-␥, and IgG aggregates [13] , modified low-density lipopro-teins (LDL) [14] , and LPS [15] , thus implying some role in inflammation. Indeed, CSF-1 regulates several mature macrophage functions including chemotaxis, adherence, antimicrobial responses, and antibody-dependent cellular toxicity (for recent reviews, see refs. [12, 16] ). For example, CSF-1 promotes cellular migration by acting directly as a chemotactic factor [17] and by up-regulating the expression of the urokinase plasminogen activator (uPA) [18] . It also primes mouse macrophages for enhanced TNF, IL-6, and IL-12 production in response to LPS [19, 20] . Such data imply a proinflammatory role for CSF-1, and in support of this conclusion, an anti-CSF-1 antibody reduced disease severity in a mouse model of rheumatoid arthritis, and administration of exogenous CSF-1 exacerbated disease [21] . A recent study by Stanley and co-workers [22] highlighted the importance of local production of CSF-1 in eliciting inflammatory responses. Macrophages from mice engineered to express CSF-1 in the same cells that express the CSF-1R produced higher levels of proinflammatory cytokine mRNAs and were primed to secrete elevated levels of these cytokines in response to LPS. This phenotype was not dependent on CSF-1 secretion and was actually enhanced compared with mice in which CSF-1 was systemically elevated [22] .
The extensive literature documenting the involvement of CSF-1 in inflammation [12, 16, 23] has led to the development of CSF-1R kinase inhibitors [20, 24 -28] . This strategy is based primarily on findings in mice, however; whether dysregulated levels of CSF-1 actually contribute causally to inflammatory disease progression in humans is unknown, as relatively few studies have focused on the acute effects of this factor on mature human macrophage function. Although some studies have performed detailed gene expression analyses of CSF-1-induced human monocyte-to-macrophage differentiation [8, 9, 29] , none have specifically explored the biological effects of acute CSF-1 stimulation in mature macrophages. As the contribution of the CSF-1/CSF-1R signaling system to inflammatory disease in humans is unclear, and a new ligand for the CSF-1R was identified recently [5] , we investigated the CSF-1 response in human monocyte-derived macrophages (HMDM) after acute CSF-1 stimulation. In so doing, we identified CSF-1-regulated genes and pathways that are likely to impact inflammatory and cardiovascular disease.
MATERIALS AND METHODS

Cell culture and reagents
"Complete" cell culture media consisted of RPMI 1640 [bone marrow-derived macrophages (BMM), Ba/F3] or IMDM (HMDM) containing 10% FCS, 20 U/ml penicillin, 20 g/ml streptomycin, and 2 mM L-glutamine (Invitrogen Life Technologies, Carlsbad, CA, USA). Cells were cultured at 37°C with 5% CO 2 . For HMDM differentiation, PBMC were separated from buffy coat (obtained from blood donations to the Australian Red Cross Blood Service, Melbourne) by Ficoll-Paque density centrifugation, and CD14 ϩ monocytes were isolated by positive selection using MACS magnetic beads (Miltenyi Biotec, Auburn, CA, USA). Monocytes were cultured overnight at 1 ϫ 10 6 /ml in complete IMDM before harvesting. MDM were differentiated in complete IMDM containing 10 4 U/ml (100 ng/ml) recombinant human (rh)CSF-1 (a gift from Chiron, Emeryville, CA, USA) on tissue-culture plastic at 1.5 ϫ 10 6 monocytes/ml. HMDM were supplemented with 50% fresh medium containing CSF-1 on Day 5 after seeding, harvested by gentle scraping in saline solution, and replated on Day 6 and used on Day 7 at 1 ϫ 10 5 MDM/cm 2 for RNA and protein analyses. BMM were derived from femurs of 6-to 8-week-old male BALB/c or C57/Bl6 mice and cultured in complete RPMI. Femurs were flushed with medium, and bone marrow cells were plated in medium containing 10 4 U/ml (100 ng/ml) rhCSF-1 on bacteriological plastic plates (Bibby Sterilin Ltd., UK) for 7 days, with refeeding on Day 5 and reseeding on Day 6 for HMDM. Ba/F3-CSF-1R, -Kit, and -fetal liver tyrosine kinase 3 (Flt3) cell lines, stably expressing full-length human CSF-1R or the CSF-1R ligand-binding domain spliced to the intracellular domains of c-Kit and Flt3, respectively, were reported previously [20] . These cell lines are CSF-1-dependent. For survival assays, cells were plated in the presence of CSF-1 and varying concentrations of GW2580 (Merck, Rahway, NJ, USA) or DMSO vehicle for 48 h and survival measured by MTT assay. LPS from Salmonella minnesota (Sigma-Aldrich, St. Louis, MO, USA) was used at a final concentration of 10 ng/ml. GW2580 (Merck) and imatinib mesylate (Gleevec) were stored at 20 mM in DMSO and used at a final concentration of 5 M unless indicated otherwise. Cholesterol (methyl-␤-cyclodextrin carrier, Sigma-Aldrich) was dissolved in water and used at 50 g/ml.
Total RNA isolation and quantitative (q)PCR Cells for expression analysis were lysed in situ, and total RNA was prepared from 1 to 3 ϫ 10 6 cells using the Qiagen RNeasy Mini kit with on-column DNaseI treatment, according to the manufacturer's instructions. RNA was reverse-transcribed using Superscript III (Invitrogen Life Technologies) and an oligo-dT primer. Gene expression was quantitated by real-time PCR using SYBR Green PCR master mix (Applied Biosystems, Foster City, CA, USA) and an Applied Biosystems Prism 7000 or 7500 sequence detector. Amplification was achieved using an initial cycle of 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 50°C for 1 min. cDNA levels during the linear phase of amplification were normalized against hypoxanthine guanine phosphoribosyl transferase (HPRT) controls using the power dCt method. Data, presented as fold change compared with untreated cells (meanϩSEM) were calculated from four to five independent HMDM preparations and a total of four to six BMM preparations from C57/Bl6J (two) and BALB/c (two to four) backgrounds. As no differences in CSF-1 responses were observed between BMM from C57/Bl6J and BALB/c mice, data from both mouse strains were combined. Statistical significance was calculated using a one-sample t-test to compare CSF-1-stimulated population means with controls (*, PϽ0.05; **, PϽ0.005; ***, PϽ0.0005). The Pearson correlation coefficient (with twotailed test for significance; see Fig. 5C ) was calculated in Prism. Gene-specific primer pairs were designed with an optimal primer size of 20 bases, amplicon size of 100 bp, and annealing temperature of 65°C. Where possible, matched primers detecting mouse and human orthologs were designed to target homologous regions in the genes. CSF-1 isoform primer efficiency was tested over a cDNA dilution series, and all three primer pairs amplified their targets with approximately equal efficiency. Primer sequences used for RT-PCR amplification appear in Table 1 , where h and m denote human and mouse target genes, respectively.
Microarray hybridization and analysis
Total RNA was amplified, labeled, and hybridized to Illumina Sentrix 6 (Version 1) bead arrays, according to the manufacturer's protocols (Illumina, San Diego, CA, USA). Arrays were scanned on an Illumina bead station and bead summary data generated using the Illumina Beadstudio software, according to the manufacturer's instructions. The summarized data from BeadStudio was imported into R/BioConductor using the Bead Explorer readBead function (v1.14.2, http://bioconductor.org/packages/1.9/bioc/vignettes/BeadExplorer/). Background adjustment and quantile normalization were performed using the bg.adjust and normalize.quantiles algorithms from the Affymetrix RMA package. Normalized data were exported using the write.beadData function for further analysis in GeneSpring GX (Agilent Technologies, Santa Clara, CA, USA), where expression data for each donor were normalized to their own unstimulated controls to analyze CSF-1 responses. Genes that were greater than or equal to twofold up-or down-regulated at 6 h CSF-1 stimulation were identified as putative, differentially regulated genes, which were required to be strongly detected (Illumina detection score of 1) at the time-point of their highest expression in at least two donors. Genes that appeared to be differentially regulated in all two or three MDM populations were tested for statistical significance by one-way ANOVA (120 genes were regulated in three of three donors; Supplemental Table 1 ). All microarray data have been deposited in National Center for Biotechnology Information's Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?tokenϭptchlggwgwkccza&accϭ GSE1106 1). CSF-1-regulated genes were scanned for gene ontology (GO) enrichment using Database for Annotation, Visualization, and Integrated Discovery (DAVID), using all human genes as the background set. P values represent Expression Analysis Systematic Explorer (EASE) scores, which are P values derived from a modified Fisher Exact test [30] .
Measurement of proinflammatory cytokine release by ELISA
BMM or HMDM were plated in 24-well plates at 5 ϫ 10 5 cells per well in 1 ml complete medium with or without CSF-1 (10 4 U/ml). The next morning, cells were stimulated with 10 ng/ml LPS, and supernatants were collected after 24 h. IL-6, TNF, and IFN-inducible protein 10 (IP-10) levels were estimated in triplicate using sandwich ELISAs (BD PharMingen, San Diego, CA, USA).
Flow cytometry
For CSF-1R cell-surface analysis, HMDM were CSF-1-starved overnight, followed by stimulation with 10 4 U/ml CSF-1 for 5 min. HMDM were harvested rapidly by gentle scraping in ice-cold PBS/0.5% BSA/0.1% NaAzide [(PBA)], blocked with 10% human serum, and 1 ϫ 10 6 cells were stained with PE-conjugated mouse anti-human CSF-1R antibody or matched isotype control (R&D Systems, Minneapolis, MN, USA). For CXCR4 surface analysis, HMDM were starved of CSF-1 overnight or stimulated with 10 4 U/ml CSF-1 in the presence of 5 M GW2580 or DMSO vehicle. Cells (1ϫ10 6 ) were harvested in PBA, blocked with 10% human serum, and stained with 0.5 g anti-CXCR4 (1G4, R&D Systems) or anti-V5 (Serotec, UK) as an isotype control, followed by staining with a FitC-conjugated goat anti-mouse secondary antibody. Immunostained samples were analyzed using a FACSCalibur cytometer (Becton Dickinson, San Jose, CA, USA).
Free cholesterol quantification
HMDM (0.5ϫ10 5 /cm 2 ) were seeded on glass coverslips and CSF-1-starved or treated with GW2580 for 16 -20 h, followed by stimulation with CSF-1 for 6 h as indicated. Cells were fixed in 4% paraformaldehyde, permeabilized in PBS/0.5% BSA with 0.1% saponin, followed by sequential staining with 1 mg/ml Filipin in PBS/0.5% BSA (Sigma-Aldrich) and Oil Red O (65% in isopropanol, Sigma-Aldrich). Images (10 -20; Ͼ100 cells) per treatment were collected randomly and analyzed using ImageJ (http://rsbweb.nih.gov/ij/). Filipin fluorescence intensity per cell was calculated by dividing total fluorescence (integrated density) by the number of cells per frame (manually counted) for 10 -20 randomly selected frames per treatment (Ͼ100 cells). Fluorescence/ cell was averaged over all frames per treatment and expressed as mean ϩ SEM.
RESULTS
CSF-1 responses of mouse BMM are not replicated in HMDM
CSF-1 regulates the function of mature mouse BMM, for example, by priming for enhanced TNF, IL-6, and IL-12p40 production in response to LPS [19] by up-regulating uPA mRNA expression [18] and by decreasing Apoe mRNA levels [20] . Surprisingly, we found that CSF-1 did not significantly regulate UPA or APOE mRNA expression in HMDM from several independent donors, in contrast to its effects on mouse BMM (Fig. 1, A and B) . Similarly, the priming effect of CSF-1 on LPS-induced TNF and IL-6 production, apparent in mouse macrophages, was not observed in HMDM (Fig. 1, C and D) . The lack of response is unlikely to be a result of autocrine CSF-1, which has been reported to regulate human monocyte/ macrophage function [31] , as the CSF-1R inhibitor GW2580 [24] had no significant effect on these responses in HMDM (data not shown). Although some of the differences between BMM and HMDM might reflect species-specific effects, the progenitors and differentiation states of the two cell popula- 
tions are also likely to be important. Others showed that CSF-1 induced UPA expression and plasminogen-dependent fibrinolytic activity in freshly elutriated human monocytes [32] , and we also found that CSF-1 modestly induced UPA mRNA expression in human monocytes (data not shown). Although CSF-1 did not exert the same biological effects identified in murine macrophages, we confirmed that HMDM do respond to acute CSF-1 stimulation. In mouse macrophages, the CSF-1R is synthesized constantly, cycles to the cell surface, and is internalized and destroyed upon ligand binding. The rate of reappearance of the surface receptor actually limits biological responses to CSF-1 [33] , and CSF-1-starved HMDM expressed the CSF-1R at the cell surface, and this was down-modulated rapidly by CSF-1 (Fig. 1E) .
Identification of novel CSF-1 target genes in human macrophages
To identify genes that require constant CSF-1 signaling in mature human macrophages, we used a microarray approach. Gene expression in HMDM, prepared from three independent blood donations stimulated with CSF-1 for 6 h compared with untreated controls, was analyzed on an Illumina Sentrix6 bead array. Notwithstanding the fact that autocrine production of CSF-1, a factor that is highly variable between HMDM from different individuals (see below), could affect constitutive expression of CSF-1 target genes, we saw robust changes in gene expression in response to exogenous CSF-1, which coordinately regulated 120 genes in HMDM from all three donors (87 induced; 33 repressed; Supplemental Table 1 ). These genes were analyzed for GO over-representation using DAVID [30] . Significantly enriched biological processes, functions, and cellular components are listed in Table 2 . CSF-1 altered transcription of genes involved in several biological processes in mature macrophages, but two prominent effects were upon the expression of the chemokine/chemokine receptor repertoire and genes encoding enzymes of the cholesterol biosynthetic pathway.
Impact of CSF-1 on the chemokinome
One of the GO categories enriched for CSF-1-regulated genes was that of chemokines, and one of the most dramatically CSF-1-repressed genes was the chemokine receptor CXCR4, which encodes the receptor for stromal-derived cell factor (SDF). We validated the microarray data by real-time PCR, demonstrating that CSF-1 repressed CXCR4 expression in HMDM ( Fig. 2A) . This effect was ablated by imatinib mesylate, which is used clinically to target the bcr-abl and c-Kit kinases, but also inhibits the CSF-1R kinase [27] (Fig. 2A) . Several groups, including our own, have developed CSF-1R kinase inhibitors with varying degrees of specificity [20, 24 -26, 28] . Based on in vitro kinase assays, GW2580 appears to be one of the most selective of these inhibitors [24] , and we confirmed the specificity of this compound in cell-based assays. GW2580 antagonized the survival signal delivered by CSF-1 in Ba/F3 cells ectopically expressing the CSF-1R but did not affect this response in Ba/F3 cells expressing the extracellular domain of CSF-1R linked to the intracellular domains of the highly related kinases c-Kit and Flt3 (Fig. 2B ) [20] . As expected, GW2580 also blocked CSF-1-mediated repression of CXCR4 mRNA expression in HMDM ( Fig. 2A) , and thus, further analyses with CSF-1R inhibitors in this study focused on this compound. Figure 2C shows that the repressive effect of CSF-1 on CXCR4 expression was apparent over a 24-h time course, and although studies about HMDM can be compromised by donor variability, this effect was remarkably consistent across multiple donors (Fig. 2D, nϭ14) . Furthermore, the effect was also apparent in mouse BMM (Fig. 2E) , thus confirming that at least some CSF-1 target genes are regulated similarly in HMDM and mouse BMM. In addition to the chemokine receptor CXCR4, CSF-1 regulated several chemokine mRNAs in HMDM. We confirmed the microarray data by real-time PCR over a CSF-1 time course. CSF-1 acutely up-regulated mRNAs encoding the C-C chemokines CCL2/MCP-1 and CCL7/MCP-3 (Fig. 3A) . In contrast to the heightened expression of chemokines associated with monocyte and lymphocyte recruitment (CCL2, CCL7), CXCL2/MIP-2, a neutrophil chemoattractant, was repressed in HMDM over the same time course (Fig. 3A) . CXCL10/IP-10, a chemokine classically associated with Th1 polarization and recruitment [34] , was also CSF-1-inducible in HMDM (Fig.  3A) . For each of these chemokines, the CSF-1-regulated response in HMDM was antagonized by GW2580 (Fig. 3B , and data not shown). Inducible IP-10 expression, as well as antagonism by GW2580, was also apparent at the protein level (Fig.  3B) , although some donor variability was observed for this response. We conclude that CSF-1 reprograms chemokine responsiveness (e.g., CXCR4) as well as the chemokine-secretion profile of HMDM. Some of these novel CSF-1 responses were also observed in mouse BMM, namely CCL2 and CCL7 induction (Fig. 3A) , but there was also considerable divergence. For example, CXCL2 was CSF-1-repressed in HMDM but induced in BMM. Conversely, CXCL10 was CSF-1-inducible in HMDM but down-regulated modestly in BMM (Fig. 3A) .
CSF-1 regulates cholesterol biosynthesis and lipid metabolism in HMDM
The most significantly over-represented ontology among CSF-1-regulated genes was that of lipid metabolism and in particular, cholesterol biosynthesis. CSF-1 significantly increased mRNA expression of at least 10 enzymes of the cholesterol biosynthetic pathway in mature human macrophages ( Table  3) . These include HMGCR, which catalyzes the rate-limiting step in cholesterol biosynthesis, as well as MVD, IDI1, and FDPS, which are involved in conversion of C 2 acetyl CoA to squalene, the first isoprenoid intermediate committed to cholesterol synthesis [35] . Downstream of squalene, CSF-1 upregulated transcripts for SQLE, CYP51A1, EBP, NSDHL, as well as DHCR7 and DHCR24 that catalyze the final step of cholesterol synthesis [35] . We validated some of these findings by real-time PCR (HMGCR, MVD, and DHCR7; Fig. 4, A-C) . CSF-1 also transiently repressed ABCG1 mRNA, which encodes the ATP-binding cassette protein G1 that mediates reverse cholesterol transport to lipid-rich apolipoproteins in macrophages [36] (Fig. 4D) . Cholesterol biosynthesis is regulated tightly by a negative-feedback loop, in which excess cholesterol leads to transcriptional repression of cholesterol biosynthetic enzymes [37] . Consequently, the addition of exogenous cholesterol blocked CSF-1-mediated up-regulation of HMGCR and DHCR7 (Fig. 4E) . Furthermore, acute CSF-1 stimulation increased levels of free cholesterol greater than or equal to twofold in HMDM, and this response was blocked by the CSF-1R kinase inhibitor GW2580 (Fig. 4F ).
Autocrine CSF-1 impacts HMDM function
Although CSF-1 consistently down-regulated CXCR4 mRNA expression in HMDM from different donors, the level of repression was variable (Fig. 2D) . This variation might reflect differences in autocrine CSF-1 action, which has been reported in human monocytes and macrophages [31] . Consistent with this notion, GW2580 up-regulated the basal expression of the CSF-1-repressed gene CXCR4 to different degrees in individual HMDM populations. In HMDM populations in which exogenous CSF-1 only modestly suppressed CXCR4 mRNA expression (Donor 1), basal expression was strongly induced (fivefold) by GW2580, and the level of endogenous CSF-1 mRNA expression was high (Fig. 5B) . In HMDM from donors where CSF-1 strongly repressed CXCR4 mRNA expression (Donor 2), GW2580 had a more modest effect on basal expression (twofold; Fig. 5A ), and much lower levels of endogenous CSF-1 mRNA were detected. The inverse correlation between CSF-1 mRNA levels and the magnitude of the response to exogenous CSF-1 was apparent in HMDM preparations from multiple donors (Fig. 5C ), implying that autocrine CSF-1 is an important, but variable, regulator of HMDM function. These effects were also confirmed at the protein level; GW2580 up-regulated basal expression of cell-surface CXCR4 and blocked the down-modulation by exogenous CSF-1 (Fig. 5D) .
Mammalian cells produce three biologically active CSF-1 isoforms [a soluble, circulating glycoprotein; a membranetethered glycoprotein; and an extracellular matrix (ECM)-anchored proteoglycan], and the primers used in Figure 5B detected all three isoforms. As emerging literature describes distinct functions for different CSF-1 isoforms [3] , we designed real-time PCR primers to distinguish among the transcripts encoding all CSF-1 protein isoforms: NM_000757.3/ NM_17221.1 encoding secreted glycoprotein and secreted proteoglycan CSF-1 (CSF-1-A), NM_172211.1 encoding cell-surface glycoprotein CSF-1 (CSF-1-C), and NM_172210.1 encoding a third CSF-1 that has not been investigated experimentally ( CSF-1-B; Fig. 5E ). It is not yet clear how CSF-1-B processing occurs; it may exist as a cell-surface and secreted protein. The first five exons of the CSF-1 transcript encode biologically active CSF-1, and splicing in Exon 6 determines how the cytokine is processed, and alternative use of Exons 9 and 10 produce distinct 3Ј untranslated regions (UTRs) that control message stability [38] . The expression of alternative 3Ј UTRs was not considered here. Although the canonical CSF-1-A transcript is generally thought to be the dominant CSF-1 isoform, all three CSF-1 transcripts were expressed in HMDM and were strongly up-regulated (more than tenfold) during monocyte-to-macrophage differentiation (Fig. 5F ). Although there are further levels of regulation involved in translating and processing CSF-1 into its biologically active forms, this observation supports a role for autocrine/paracrine CSF-1 in human macrophage maturation and function.
DISCUSSION
The homeostatic functions of CSF-1 in the differentiation and maintenance of macrophages are relatively well characterized. Although this cytokine is always present, local and systemic CSF-1 levels actually increase in a range of diseases, and the effects of this elevated CSF-1 on mature macrophage function in humans are not well understood. Direct links between CSF-1 and inflammatory disease pathogenesis have been demonstrated in animal models, including rheumatoid arthritis [21] , inflammatory bowel disease [39] , and atherosclerosis [40] . Consequently, several groups, including our own, have pursued selective inhibitors against the CSF-1R kinase [20, 24, 28, 41] . Despite this focus on the CSF-1R as a drug target, the majority of direct evidence linking CSF-1 with inflammatory disease has been collected in species other than human (mainly rodents). Certain proinflammatory effects of CSF-1, apparent in mouse BMM (e.g., amplification of LPS-induced TNF and IL-6), were not observed in HMDM (Fig. 1, C and D) . These effects are well established in the mouse, in vitro and in vivo, in a range of macrophage populations [19, 20, 42] . Although CSF-1 did not prime TNF and IL-6 production in HMDM, several of the CSF-1-regulated chemokines that we identified in HMDM have well-documented roles in inflammation. Acute CSF-1 stimulation increased expression of the monocyte-and lymphocyteattracting chemokines CCL2, CCL7 (both of which signal via CCR2), and CXCL10, while repressing transcription of the neutrophil chemoattractant CXCL2 (Fig. 3) . CSF-1 could thus be anticipated to alter the balance of immune effector cells in tissue microenvironments, favoring monocytes and lymphocytes over neutrophils. CCL2/MCP-1 plays a major, nonredundant role in monocyte recruitment into tissues during inflammation and has been implicated in a wide range of inflammatory diseases characterized by monocyte-rich infiltrates, including atherosclerosis, rheumatoid arthritis, and multiple sclerosis (reviewed in ref. [43] ). Similarly, CCL7/MCP-3 was required for monocyte mobilization from bone marrow and recruitment to inflammatory sites in mice [44] . CXCL10/IP-10, a potent chemoattractant for monocytes and activated T lymphocytes, enhances inflammatory cell adhesion to the vascular endothelium, further facilitating their recruitment to sites of inflammation [45] . Although low levels of IP-10 are detected in normal human serum, increases in circulating IP-10 are associated with a number of chronic inflammatory diseases including rheumatoid arthritis, atherosclerosis, and diabetes [46 -48] . It is therefore possible that this increase is influenced by an elevation in local or circulating CSF-1, which is also commonly associated with such conditions [12, 49] .
Given the evidence supporting a proatherogenic function for CSF-1 in mice [40, 50, 51] and disparate data suggesting CSF-1 is atheroprotective in rabbits [52] [53] [54] , it is interesting that a common thread linking the CSF-1-responsive genes, identified in this study about human macrophages, is their association with atherosclerosis. All three CSF-1-inducible chemokines identified here have been implicated previously in atherosclerosis, and the evidence for CCL2 involvement was particularly strong [43, 46, 55] . The recruitment of circulating monocytes to atherosclerotic lesions was absolutely dependent on the receptor for CCL2, CCL7, and CCR2 [56] . In addition to inducing proatherogenic chemokines, CSF-1 down-regulated CXCR4 mRNA and cell-surface protein expression (Figs. 2  and 5 ). CXCR4 is the receptor for SDF/CXCL12, and interference with the SDF-1/CXCR4 axis aggravated atherosclerosis through enhanced leukocyte recruitment to plaques [57] . Thus, CSF-1 has pronounced proatherogenic effects on the macrophage chemokinome.
Atherosclerosis is a disease of hypercholesterolemia, in which lipid accumulation in vessel walls leads to monocyte infiltration and differentiation into lipid-laden foam cells. Proteoglycan-CSF-1 has been shown to bind LDL with high affinity [58] , and it has been suggested that CSF-1 embedded in the ECM is involved in lipoprotein retention, leading to increased susceptibility to oxidation, increased aggregation, and increased lipid internalization by macrophages [59] . CSF-1 can also act more directly in this process; it enhanced the uptake and degradation of modified LDL and cholesterol esterification by human macrophages in vitro [60] . Our data further implicate CSF-1 in lipid homeostasis, suggesting this cytokine promotes cholesterol biosynthesis and/or its intracellular retention. HMDM accumulated free cholesterol in response to acute (6 h) CSF-1 stimulation (Fig. 4F) , contemporaneous with the induction of cholesterol biosynthetic genes and repression of the cholesterol exporter ABCG1 (Fig. 4 , A-D, and Table 3 ).
As free cholesterol is a toxic metabolite [61] , cellular cholesterol homeostasis is finely regulated by multiple negativefeedback mechanisms at the level of uptake, synthesis, esterification, and export [37] . The balance between free and esterified cholesterol is progressively unbalanced during atherogenesis, and the resulting excess of free cholesterol may heighten inflammatory responses and contribute to apoptosis of lesional cells and ultimately to plaque rupture [61, 62] . Intriguingly, in addition to genes controlling cholesterol biosynthesis, CSF-1 induced HSPA5/GRP78, a molecular chaperone whose induction is a hallmark of the unfolded protein response (UPR) [63, 64] in all three donors in our microarray study (Supplemental Table 1 ). In macrophages, the UPR is activated by free cholesterol accumulation [65, 66] and during lesion development in atherosclerotic mice [65] . Thus, elevated levels of CSF-1 may contribute to disease progression by inducing free cholesterol accumulation in macrophages, which in turn, constitutes a source of endoplasmic reticulum stress.
The local environment may further magnify the importance of CSF-1 in atherosclerosis. The proatherogenic effects of CSF-1 are likely to be mediated by local CSF-1 (presumably the cell-surface or ECM-anchored isoform) [12, 59] . Oxidized LDLs induced CSF-1 expression in aortic endothelial and smooth muscle cells [67] , and we show here that human macrophages themselves express mRNAs for secreted glycoprotein, secreted proteoglycan, and cell-surface CSF-1 and up-regulate all three isoforms during maturation (Fig. 5) . Thus, multiple cell types present in atherosclerotic lesions express CSF-1, which can act on HMDM to elicit proatherogenic responses. Indeed, macrophages differentiated in the presence of CSF-1 had a similar immunophenotype to those present in atherosclerotic lesions [8] .
CSF-1 regulation of CXCR4 expression is of interest for several reasons other than the relevance to atherogenesis. Although CXCR4 down-regulation upon monocyte-to-macrophage differentiation has been reported [68] , our studies show that it is also acutely repressed by CSF-1 in mature macrophages and that this suppressive effect is reversible (Fig. 5) . Although SDF/CXCL12 signaling via CXCR4 has been classically associated with homeostatic leukocyte homing, it can also regulate the survival and proliferation of several cell types, including myeloid cells [69] . As SDF/CXCL12 mRNA is also expressed by HMDM (unpublished data), and HMDM respond to SDF [68] , it is plausible that the SDF/CXCR4 axis acts as an autocrine loop for cell survival in HMDM, when CSF-1 levels are limiting. A further consequence of CSF-1-mediated CXCR4 down-regulation may be the mobilization of blood monocytes. Disruption of SDF-1/CXCR4 signaling in the bone marrow, by blocking the action of ligand or receptor, promotes hematopoietic stem-cell mobilization into the blood [70] . As in vivo administration of CSF-1 results in a dramatic increase in the pool of circulating blood monocytes [71] , CSF-1 suppression of CXCR4 expression may contribute to monocyte mobilization.
In summary, we have identified novel CSF-1 target genes in mature human macrophages that provide insight into the function of this cytokine in health and disease. Our findings suggest that in humans, CSF-1 provides a molecular link between inflammation and cardiovascular disease by regulating pathways that stimulate cholesterol accumulation and a proatherogenic chemokine environment. CSF-1 antagonists may thus have future applications in the treatment of cardiovascular disease. Apart from the obvious relevance of our findings to human disease, this study illustrates several differences between BMM and HMDM, arguably the most commonly used ex vivo models of human and mouse macrophages. A growing body of evidence suggests that innate immune cells and their responses differ between humans and mice in numerous respects [72, 73] . Whether some or all of the differences that we observe truly reflect species-specific effects, the heterogeneity of macrophages derived from different origins or both is unknown. Nonetheless, they highlight the importance of establishing the relevance of mouse models for the study of human inflammatory diseases.
